18
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of 3,4,3-LIHOPO for Reducing the Retention of Uranium in Rat after Acute Administration

, , , &
Pages 389-393 | Received 06 Mar 1995, Accepted 15 Jun 1995, Published online: 03 Jul 2009

References

  • Archimbaud M., Henge-Napoli M.H., Lilienbaum D., Desloges M., Montagne C. Application of Calixarenes for the decorporation of uranium: present limits and further trends. Radiation Protection Dosimetry 1994; 53: 327–330
  • Basinger M.A., Jones M.M. Tiron (Sodium 4,5-dihydrobenzene-1-3-disulfonate) as an antidote for acute uranium intoxication in mice. Research Communications in Chemical Pathology and Pharmacology 1981; 34: 351–358
  • Bhattacharyya M.H., Breitenstein B., Metivier H., Muggenburg B.A., Stradling G.N., Volf V. Guidebook for the treatment of accidental internal radionuclide contamination of workers. Radiation Protection Dosimetry 1992; 41: 27–36
  • Berlin M., Rudell B. Uranium. Handbook on the Toxicology of Metals, G.F. Nordberg, V.B. Vouk. Elsevier. 1979; 647–658, In
  • Domingo J.L., Ortega A., Llobet J.M., Paternain J.L., Corbella J. The effects of repeated parenteral administration of chelating agents on the the distribution and excretion of uranium. Research Communications in Pathology and Pharmacology 1989; 64: 161–164
  • Domingo J.L., Ortega A., Llobet J.M., Corbella J. Effectiveness of chelation therapy with time after acute uranium intoxication. Fundamental and Applied Pharmacology 1990; 14: 88–95
  • Durbin P.W., Jeung N., Rodgers S.J., Turowski P.N., Weitl F.L., White D.L., Raymond K.N. Removal of 238Pu from mice by polycatechoylate, -hydroxamate or-hydroxypyridinonate ligands. Radiation Protection Dosimetry 1989; 1: 351–358
  • Durbin P.W., Kullgren B., Xu J., Raymond K.N. In vivo chelation of Am(III), Pu(IV), Np(V) and U(VI) in mice by TREN-(Me-3,2-HOPO). Radiation Protection Dosimetry 1994; 53: 305–309
  • Fisher D.R. Uranium. Handbook on the Toxicity of Inorganic Compounds, G. Seiler, H. Sigel, New York 1988; 739–748, In
  • Fritsch P., Herbreteau D., Moutairou K., Lantenois G., Richard le Naour H., Grillon G., Hoffschir D., Poncy J.L., Laurent A., Masse R. Comparative toxicity of 3,4,3-LIHOPO and DTPA in baboons: preliminary results. Radiation Protection Dosimetry 1994; 53: 315–318
  • Gray S.A., Sato H., Stradling G.N., Pearce M.J., Burgada R. The efficacy of some phosphonic acid derivatives for enhancing the excretion of uranium in the rat. EULEP Newsletter 1995; 79: 14–14
  • Harley J.H. Manual of Standard Procedures3rd edn. US AEC Report NYO-4700, Internal publication, New York 1970
  • Hodge H.C. A history of uranium poisoning (1824–1942). Uranium, Plutonium, Transplutonic Elements, H.C. Hodge, J.B. Hursh. Springer, New York 1973; 165–196, In
  • Ivannikov A.T. Medicative application of complexons in the case of uranium intoxication, Report Oil-5-87. Central Scientific Research Institute, Moscow 1987
  • McNider W. de B. The inhibition of the toxicity of uranium nitrate by sodium carbonate, and the protection of the kidney acutely nephropathic from uranium or from the toxic action of an anesthetic by sodium carbonate. Journal of Experimental Medecine 1916; 23: 171–187
  • Metivier H. CEC-USDOE Guidebook for the treatment of internal contamination of workers: an overview. Radiation Protection Dosimetry 1994; 53: 291–295
  • Pasquier M., Bourguignon M.C. Thérapeutique des contaminations par l'uranium. C.R.S.S.A. 76 Travaux Scientifiques 1977, no. 6: 149–154
  • Pasquier C., Mestries J.C., Caraiannis M. Traitement des contaminations aiguës à l'uranium. Essai de l'acétazolamide. C.R.S.S.A. 76 Travaux Scientifiques 1979, no. 1: 148–150
  • Poncy J.L., Rateau G., Burgada R., Bailly T., Leroux Y., Raymond K.N., Durbin P.W., Masse R. Efficacy of 3,4,3-LIHOPO for reducing the retention of 238Pu in rat after inhalation of the tributyl phosphate complex. International Journal of Radiation Biology 1993; 64: 431–436
  • Stradling G.N., Gray S.A., Moody J.C., Ellender M. Efficacy of Tiron for enhancing the excertion of uranium from the rat. Human and Experimental toxicology 1991; 10: 195–198
  • Stradling G.N., Gray S.A., Ellender M., Moody J.C., Hodgson A.G., Pearce M., Wilson I., Burgada R., Bailly T., Leroux Y.G.P., El Manouni D., Raymond K.N., Durbin P.W. The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophores analogues. International Journal of Radiation Biology 1992; 62: 487–497
  • Stradling G.N., Gray S.A., Moody J.C., Hodgson A.G., Pearce M., Wilson I., Burgada R., Bailly T., Leroux Y.G.P., Raymond K.N., Durbin P.W. Comparative efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat after simulated wound contamination as nitrate. International Journal of Radiation Biology 1993; 64: 133–140
  • Taylor D.M., Gillis T.M. Correlation of biokinetic behaviour and physicochemical parameters within chemical families: alkali metals and lanthanides. Radiation Protection Dosimetry 1994; 53: 183–186
  • Volf V., Wirth R. Effective chelation therapy after incorporation of Neptunium-239 in rats. International Journal of Radiation Biology 1986; 50: 955–959
  • White D.L., Durbin P.W., Jeung N., Raymond K.N. Specific sequestering agents for the actinides, 16. Synthesis and initial biological testing of polydentate oxohydroxypyridine carboxylate ligands. Journal of Medicinal Chemistry 1988; 31: 11–18
  • Wrenn Mc D.E., Durbin P.W., Willis D.L., Singh N.P. The potential toxicity of uranium in water. Journal of the American Water Works Association 1987; 79: 177–184

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.